Cargando…

Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules

Detalles Bibliográficos
Autores principales: Gatignol, A, Scarborough, RJ, Lévesque, MV, Boudrias-Dalle, E, Chute, IC, Daniels, SM, Ouellette, RJ, Perreault, J-P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220865/
http://dx.doi.org/10.1186/1471-2334-14-S2-O19
_version_ 1782342796815892480
author Gatignol, A
Scarborough, RJ
Lévesque, MV
Boudrias-Dalle, E
Chute, IC
Daniels, SM
Ouellette, RJ
Perreault, J-P
author_facet Gatignol, A
Scarborough, RJ
Lévesque, MV
Boudrias-Dalle, E
Chute, IC
Daniels, SM
Ouellette, RJ
Perreault, J-P
author_sort Gatignol, A
collection PubMed
description
format Online
Article
Text
id pubmed-4220865
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42208652014-11-10 Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules Gatignol, A Scarborough, RJ Lévesque, MV Boudrias-Dalle, E Chute, IC Daniels, SM Ouellette, RJ Perreault, J-P BMC Infect Dis Oral Presentation BioMed Central 2014-05-23 /pmc/articles/PMC4220865/ http://dx.doi.org/10.1186/1471-2334-14-S2-O19 Text en Copyright © 2014 Gatignol et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Gatignol, A
Scarborough, RJ
Lévesque, MV
Boudrias-Dalle, E
Chute, IC
Daniels, SM
Ouellette, RJ
Perreault, J-P
Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules
title Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules
title_full Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules
title_fullStr Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules
title_full_unstemmed Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules
title_short Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules
title_sort towards gene therapy against hiv-1: new therapeutic target in gag rna accessible to ribozymes and rna interference molecules
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220865/
http://dx.doi.org/10.1186/1471-2334-14-S2-O19
work_keys_str_mv AT gatignola towardsgenetherapyagainsthiv1newtherapeutictargetingagrnaaccessibletoribozymesandrnainterferencemolecules
AT scarboroughrj towardsgenetherapyagainsthiv1newtherapeutictargetingagrnaaccessibletoribozymesandrnainterferencemolecules
AT levesquemv towardsgenetherapyagainsthiv1newtherapeutictargetingagrnaaccessibletoribozymesandrnainterferencemolecules
AT boudriasdallee towardsgenetherapyagainsthiv1newtherapeutictargetingagrnaaccessibletoribozymesandrnainterferencemolecules
AT chuteic towardsgenetherapyagainsthiv1newtherapeutictargetingagrnaaccessibletoribozymesandrnainterferencemolecules
AT danielssm towardsgenetherapyagainsthiv1newtherapeutictargetingagrnaaccessibletoribozymesandrnainterferencemolecules
AT ouelletterj towardsgenetherapyagainsthiv1newtherapeutictargetingagrnaaccessibletoribozymesandrnainterferencemolecules
AT perreaultjp towardsgenetherapyagainsthiv1newtherapeutictargetingagrnaaccessibletoribozymesandrnainterferencemolecules